- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04436354
The Effect of Trendelenburg Lithotomy Position on Pain and Procedural Time During Vaginoscopic Office Hysteroscopy
September 19, 2021 updated by: Fatma ketenci gencer, Gaziosmanpasa Research and Education Hospital
The present study revealed that the TL position is supposed to be more efficient not only for lowering pain score but also reducing the procedural time.
Also, performing hysteroscopy in this position may be easier for doctors than in the lithotomy position.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
VOH is a widely used diagnostic method and seems to be getting more into outpatient clinics.
Despite its huge contribution to clinical practice, pain during the procedure is an important limiting factor.
We aimed to investigate the effect of the trendelenburg lithotomy position to the pain and procedural time.However, there is a scarcity of research on this subject.
Therefore, the rationale of the study was to enlighten the gap in the literature regarding the pain score and procedural time during VOH for diagnostic purposes in TL position.
In order to gain scientific evidence, a randomized controlled trial was conducted to compare pain score and duration of procedure between the standard lithotomy position and TL position.
Also, the convenience for the physician performing the procedure was assessed.
To the best of our knowledge, this is the first study in the literature investigating the effect of the position of the patient during the procedure on both time, pain, and the convenience for the physician simultaneously.
Study Type
Interventional
Enrollment (Actual)
157
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34255
- Saglik Bilimleri University Gaziosmanpasa Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- uterine disorders
- abnormal uterine bleeding
- infertility
Exclusion Criteria:
- pregnancy
- cervical disorders
- pelvic infections
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: vaginoscopic office hysteroscopy in the trendelenburg position
|
comparison of procedural time and pain scores of patients in different gynecologycal positions
Other Names:
|
EXPERIMENTAL: vaginoscopic office hysteroscopy in lithotomy position
|
comparison of procedural time and pain scores of patients in different gynecologycal positions
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Score for pain
Time Frame: 12 months
|
The Visual Pain Scale (VPS) was used to evaluate pain levels with 0 represented pain-free, while 10 described the most severe pain (Ekin et al. 2009; Price et al. 1983).
Patients were asked to mark the pain expressing point on the VPS immediately after VOH.
The severity of pain is determined by the value of the point (cm) marked by the participant
|
12 months
|
procedural times
Time Frame: 12 months
|
minutes
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
attitudinal Likert type survey
Time Frame: 12 months
|
with a 5-point attitudinal Likert type survey; a psychometric scale commonly used to score responses in a questionnaire. The ease or difficulty of the procedure was categorized as 1-very easy, 2-easy, 3-ineffective, 4-difficult, 5-very difficult, and the physician performing the procedure marked the appropriate section for each VOH procedure in the scale. |
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 1, 2018
Primary Completion (ACTUAL)
January 1, 2019
Study Completion (ACTUAL)
April 16, 2019
Study Registration Dates
First Submitted
June 11, 2020
First Submitted That Met QC Criteria
June 15, 2020
First Posted (ACTUAL)
June 18, 2020
Study Record Updates
Last Update Posted (ACTUAL)
September 24, 2021
Last Update Submitted That Met QC Criteria
September 19, 2021
Last Verified
June 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GaziosmanpasaTREHa
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uterine Diseases
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedUterine Corpus Leiomyosarcoma | Stage IIA Uterine Sarcoma | Stage IIB Uterine Sarcoma | Stage IIIA Uterine Sarcoma | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma | Stage IVB Uterine Sarcoma | Stage IA Uterine Sarcoma | Stage IB Uterine Sarcoma | Stage IC Uterine SarcomaUnited States
-
University of AarhusRecruitingUterine Cervical Neoplasm | Mass Screening | Uterine Cervical Disease | Uterine NeoplasmDenmark
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedUterine Carcinosarcoma | Stage IIA Uterine Sarcoma | Stage IIB Uterine Sarcoma | Stage IIIA Uterine Sarcoma | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma | Stage IVB Uterine Sarcoma | Stage IA Uterine Sarcoma | Stage IB Uterine Sarcoma | Stage IC Uterine SarcomaUnited States
-
GlaxoSmithKlineCompletedCervical Cancer | Neoplasms, Uterine Cervix
-
Huazhong University of Science and TechnologyChongqing University Cancer Hospital; Peking University People's Hospital; Qilu... and other collaboratorsRecruitingCervical Cancer | Uterine Cervical Cancer | Uterine Cervical NeoplasmChina
-
Huazhong University of Science and TechnologyUnknownCervical Cancer | Uterine Cervical Cancer | Uterine Cervical NeoplasmChina
-
Hillel Yaffe Medical CenterUnknownUterine Neoplasms | Uterine Cervical NeoplasmIsrael
-
Centre Oscar LambretTerminatedUterine Cervical CancerFrance
-
Ding MaRecruitingUterine Cervical NeoplasmChina
-
Karolinska InstitutetKarolinska University Hospital; Regional Cancer Centre Stockholm GotlandEnrolling by invitationUterine Cervical CancerSweden
Clinical Trials on vaginoscopic office hysteroscopy
-
Assiut UniversityUnknown
-
Cairo UniversityCompleted
-
Centro Hospitalar Tondela-ViseuMarta Fernandes, M.D. MSc; Sonia Gonçalves, M.D; José Damasceno Costa, M.D.; Antonio... and other collaboratorsCompletedPelvic Girdle PainPortugal
-
Cairo UniversityUnknown
-
Woman's Health University Hospital, EgyptTerminatedRecurrent Pregnancy LossesEgypt
-
Assiut UniversityCompleted
-
Hvidovre University HospitalCompletedRecurrent Miscarriages | Habitual AbortionsDenmark
-
Assiut UniversityUnknownIntracytoplasmic Sperm Injection ,Hysteroscopicaly Detected Cervical PathologiesEgypt
-
University of Campania "Luigi Vanvitelli"CompletedEndometrial Hyperplasia | PCOS | Infertility, FemaleItaly